24
Participants
Start Date
February 23, 2022
Primary Completion Date
March 24, 2022
Study Completion Date
March 31, 2022
Metformin Hydrochloride 500 MG
Metformin is an antihyperglycemic drug used in the management of type-2 diabetes. Metformin hydrochloride improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
PT Pharma Metric Labs, Jakarta Pusat
PT Pharma Metric Labs
INDUSTRY
PT. Pyridam Farma Tbk
INDUSTRY